VibeOne: AI due diligence for therapeutics
Identify, evaluate, and prioritize new assets with speed, consistency, and confidence
Built for repeatable, defensible BD decisions
Drive pipeline growth by making search and evaluation decisions with speed and discipline
Source
Gain a complete view of assets across indications, stages, and geographies, ensuring no relevant opportunities are missed
Prioritize
Focus your strategy on the therapeutic areas with the highest potential, aligning time, capital, and resources to the opportunities that matter most.
Evaluate
Apply consistent, strategy-aligned criteria to assess scientific, clinical, and competitive risk early
Decide
Support confident, defensible go / no-go BD decisions with outputs aligned across BD, R&D, and leadership
From unstructured documents to decisions—in days
VibeOne helps you move faster and de-risk decisions across the BD funnel. Whether you’re exploring new opportunities or evaluating a shortlist, our expert-guided AI delivers strategic clarity—fast.
VibeOne capabilities
Understand & target the full landscape of potential assets
Approach scientific & clinical assessments with clarity
Track catalysts that impact data and strategic decisions
Triage opportunities & prioritize based on the latest information
“A mission-driven culture, with patient impact as the North Star, is essential, and objectivity is equally important. Be willing to walk away if the data doesn’t support a program.”
Shalini Sharp, experienced board member and former biotech CFO
Accelerate confident go / no-go decisions for promising therapeutics
Too many opportunities. Too little time. VibeOne helps business development and in-licensing teams cut through the noise, identify high potential programs quickly, and deep dive into the assets that truly fit your strategy.
Accelerate time to insight, without biases
Learn how VibeOne boosts your business development or portfolio prioritization projects.